These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 15002324

  • 1. [The influence of betaserk and cinarizine on vestibular function, highest nervous activity and brain circulation in chronic cerebral ischemia: a model study].
    Grishina TR, Gromova OA, Sadin AV, Nazarenko OA, Zhidomorov NIu, Borzunov MP, Vatsuro AA, Nikonov AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(2):61-3. PubMed ID: 15002324
    [No Abstract] [Full Text] [Related]

  • 2. [The influence of cinnarizine and alvityl on cerebral blood flow and high nervous activity in chronic cerebral ischemia model].
    Gromova OA, Grishina TR, Sadin AV, Nikonov AA, Nazarenko OA, Zhidomorov NIu, Vatsuro AA, Borzunov MP.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):52-3. PubMed ID: 14870694
    [No Abstract] [Full Text] [Related]

  • 3. [Phezam efficacy in patients with chronic cerebral ischemic disease].
    Boĭko AN, Kabanov AA, Es'kina TA, Sheliakina LA, Shchukin AI, Batysheva TT, Artemova IIu, Vdovichenko TV, Volovets SA, Ganzhula PA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):36-41. PubMed ID: 15704481
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness of betaserk in vestibular disorders].
    Abdulkerimov KhT, Markov IS, Usachev VI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(6):50-2. PubMed ID: 12101896
    [No Abstract] [Full Text] [Related]

  • 5. [Vertigo in medical practice].
    Boĭko NV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):74-7. PubMed ID: 15704490
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy in the early stage of cerebral insufficiency. Clinical and technical possibilities for evaluating the vascular system].
    Fortschr Med Suppl; 1986; 1():9-10. PubMed ID: 2868982
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A concept of therapy oriented to pathophysiology. Calcium antagonists increase hypoxia tolerance].
    Fortschr Med Suppl; 1986; 1():6-7. PubMed ID: 2419232
    [No Abstract] [Full Text] [Related]

  • 9. The influence of calcium channel blockers on the central action of clonidine.
    Czarnecka E, Tymczyszyn W.
    Pol J Pharmacol; 1994; 46(3):125-31. PubMed ID: 8000443
    [Abstract] [Full Text] [Related]

  • 10. [Omaron in the restorative treatment of patients with chronic cerebrovascular insufficiency].
    Stroganova IM, Kiparisov MA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):70-2. PubMed ID: 20443242
    [No Abstract] [Full Text] [Related]

  • 11. [GABA reuptake by rat brain slices in hypokinesia and under the influence of cinnarizine and flunarizine].
    Mirzoian NR, Akopian VP, Kocharian AZh, Knarian VA, Arakelian LN, Gevorkian GA.
    Eksp Klin Farmakol; 1998; 61(5):15-7. PubMed ID: 9854625
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Flunarizine treatment in dizzy patients with vestibular hyperreactivity and hyperventilation.
    Theunissen EJ, Huygen PL, Nicolasen MG.
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(4):203-8. PubMed ID: 3523367
    [Abstract] [Full Text] [Related]

  • 14. Treatment of multiple sclerosis with interferon beta 1b.
    Dhib-Jalbut S, McFarland HF.
    Baillieres Clin Neurol; 1997 Oct; 6(3):467-80. PubMed ID: 10101584
    [Abstract] [Full Text] [Related]

  • 15. [Betaserc in the treatment of vestibular disorders in syndrome of vegetative dystonia].
    Putilina MV, Kuznetsova IuI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004 Oct; 104(9):53-4. PubMed ID: 15490942
    [No Abstract] [Full Text] [Related]

  • 16. Functional, behavioral, and histological changes induced by transient global cerebral ischemia in rats: effects of cinnarizine and flunarizine.
    Poignet H, Beaughard M, Lecoin G, Massingham R.
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):646-54. PubMed ID: 2777934
    [Abstract] [Full Text] [Related]

  • 17. Brain ischemia as a target for Ca2+ entry blockers.
    Wauquier A, Ashton D, Clincke GH.
    Ann N Y Acad Sci; 1988 Oct; 522():478-90. PubMed ID: 3288057
    [No Abstract] [Full Text] [Related]

  • 18. Interferon-beta: a novel way to treat nephrotic syndrome?
    Rees AJ, Kain R.
    J Am Soc Nephrol; 2007 Nov; 18(11):2797-8. PubMed ID: 17942945
    [No Abstract] [Full Text] [Related]

  • 19. Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessment.
    Van Reempts J, Borgers M, Van Dael L, Van Eyndhoven J, Van De Ven M.
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):76-88. PubMed ID: 6870389
    [Abstract] [Full Text] [Related]

  • 20. [The advantages of associating ischemia/reperfusion injury inhibitors with intravenous thrombolysis when treating focal brain ischemia: a description of experiments using rats].
    Alonso de Leciñana M, Díez-Tejedor E, Carceller F, Vega A, Roda JM.
    Rev Neurol; 1996 Feb; 24(126):207-13. PubMed ID: 8714490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.